These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 31394893)

  • 1. Diagnosis and Management of Gastric Intestinal Metaplasia: Current Status and Future Directions.
    Huang RJ; Choi AY; Truong CD; Yeh MM; Hwang JH
    Gut Liver; 2019 Nov; 13(6):596-603. PubMed ID: 31394893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, risk factors, and surveillance patterns for gastric intestinal metaplasia among patients undergoing upper endoscopy with biopsy.
    Huang RJ; Ende AR; Singla A; Higa JT; Choi AY; Lee AB; Whang SG; Gravelle K; D'Andrea S; Bang SJ; Schmidt RA; Yeh MM; Hwang JH
    Gastrointest Endosc; 2020 Jan; 91(1):70-77.e1. PubMed ID: 31425693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines.
    Dinis-Ribeiro M; Shah S; El-Serag H; Banks M; Uedo N; Tajiri H; Coelho LG; Libanio D; Lahner E; Rollan A; Fang JY; Moreira L; Bornschein J; Malfertheiner P; Kuipers EJ; El-Omar EM
    Gut; 2024 Sep; 73(10):1607-1617. PubMed ID: 39122364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric Intestinal Metaplasia: Real Culprit or Innocent Bystander as a Precancerous Condition for Gastric Cancer?
    Sugano K; Moss SF; Kuipers EJ
    Gastroenterology; 2023 Dec; 165(6):1352-1366.e1. PubMed ID: 37652306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA.
    Trieu JA; Bilal M; Saraireh H; Wang AY
    Dig Dis Sci; 2019 May; 64(5):1079-1088. PubMed ID: 30771043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low prevalence of gastric intestinal metaplasia and Helicobacter pylori on surveillance upper endoscopy in Lynch syndrome.
    Pulaski M; Dungan M; Weber M; Constantino G; Katona BW
    Fam Cancer; 2024 Mar; 23(1):23-27. PubMed ID: 38291131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile reflux and bile acids in the progression of gastric intestinal metaplasia.
    Qu X; Shi Y
    Chin Med J (Engl); 2022 Jul; 135(14):1664-1672. PubMed ID: 35940882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric intestinal metaplasia - age, ethnicity and surveillance for gastric cancer.
    Simko V; Anand N; Ginter E
    Bratisl Lek Listy; 2015; 116(1):3-8. PubMed ID: 25666954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric intestinal metaplasia: when to treat? How to treat?
    Abdelfattah T; Shahab O; Shah TU
    Curr Opin Gastroenterol; 2021 Nov; 37(6):602-608. PubMed ID: 34432654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.
    Watari J; Das KK; Amenta PS; Tanabe H; Tanaka A; Geng X; Lin JJ; Kohgo Y; Das KM
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):409-17. PubMed ID: 18321787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Gastric Cancer Among Patients With Intestinal Metaplasia of the Stomach in a US Integrated Health Care System.
    Reddy KM; Chang JI; Shi JM; Wu BU
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1420-5. PubMed ID: 27317852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Progression of Gastric Intestinal Metaplasia Is Significantly Greater When Detected in Both Antrum and Body.
    O'Connor A; Bowden A; Farrell E; Weininger J; Crowther S; McNamara D; Ridgway P; O'Morain C
    Dig Dis Sci; 2021 Oct; 66(10):3470-3475. PubMed ID: 33094451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
    Liu KS; Wong IO; Leung WK
    World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving Adherence to Clinical Practice Guidelines for Managing Gastric Intestinal Metaplasia Among Gastroenterologists at a US Academic Institution.
    Jacob J; Millien V; Berger S; Hernaez R; Ketwaroo GA; Flores AG; Hou JK; Jarbrink-Sehgal ME; Khalaf NI; Rosen DG; El-Serag HB; Tan MC
    J Clin Gastroenterol; 2024 May-Jun 01; 58(5):432-439. PubMed ID: 37436841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric Intestinal Metaplasia in Mucosa Adjacent to Gastric Cancers Is Rarely Associated With the Aneuploidy That Is Characteristic of Gastric Dysplasia or Cancer.
    Zhang R; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
    Am J Surg Pathol; 2021 Oct; 45(10):1374-1381. PubMed ID: 34091484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnifying endoscopy with narrow-band imaging for diagnosis of subtype of gastric intestinal metaplasia.
    Kanemitsu T; Uedo N; Ono T; Nimura S; Hasegawa R; Imamura K; Ohtsu K; Ono Y; Miyaoka M; Ueki T; Tanabe H; Ohta A; Iwashita A; Yao K
    J Gastroenterol Hepatol; 2023 Jan; 38(1):94-102. PubMed ID: 36268636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population.
    Tan MC; Ho Q; Nguyen TH; Liu Y; El-Serag HB; Thrift AP
    Dig Dis Sci; 2022 Sep; 67(9):4500-4508. PubMed ID: 34797447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice.
    Quach DT; Hiyama T; Gotoda T
    World J Gastroenterol; 2019 Jul; 25(27):3546-3562. PubMed ID: 31367156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection.
    de Vries AC; Haringsma J; Kuipers EJ
    Helicobacter; 2007 Feb; 12(1):1-15. PubMed ID: 17241295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of clinical usefulness of Das-1 monoclonal antibody and mucin expression as risk markers of gastric carcinoma in patients with gastric intestinal metaplasia.
    Forné M; Fernández-Bañares F; González-Mínguez C; Casalots J; Poblet-Mas N; Garcia-Gil LJ; Esteve M; Rosinach M; Espinós J; Loras C; Salas A; Viver JM
    Am J Clin Pathol; 2009 Jan; 131(1):99-105. PubMed ID: 19095572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.